Daniel Rødbro Burmester
Psychiatrist at Copenhagen University Hospital Rigshospitalet / affiliated with the University of Copenhagen
Data updated
Research Footprint
Daniel Rødbro Burmester appears in 5 tracked papers (2019–2023), most studied alongside Psilocybin, across Depressive Disorders, Neuroimaging & Brain Measures and Healthy Volunteers.
Most-cited paper: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (491 citations).
Frequent co-authors: Gitte Knudsen, Patrick Fisher and Dea Stenbæk.
Background & Research
Daniel Rødbro Burmester is a Danish psychiatrist and researcher associated with the Neurobiology Research Unit / NeuroPharm at Copenhagen University Hospital Rigshospitalet and the University of Copenhagen. His published work includes human psilocybin studies on 5-HT2A receptor occupancy, receptor binding, mindfulness, and subacute inflammatory changes. He also appears in Danish psychiatric professional writing and hospital-affiliated research outputs.
Key Impact
He is a coauthor on multiple human psilocybin PET and clinical studies linking 5-HT2A receptor biology to psychedelic subjective effects, mindfulness, and inflammatory biomarkers.
Collaboration Network
12 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Daniel Rødbro Burmester is associated with.